How XERMELO helps
Get beyond the nearest bathroom with XERMELO
In a 12-week study, 89% of people taking XERMELO had a reduction in diarrhea frequency, compared to 69% of patients who were on somatostatin analog (SSA) treatment alone.1,2
How XERMELO was studied
Significant improvement in 12 weeks
Most patients see significant improvement in 12 weeks, and some patients may start to see results within 3 weeks1,2
Treating your Carcinoid Syndrome Diarrhea (CSD) with XERMELO plus SSA may take up to 12 weeks to reach the full effect.1 So, make sure to tell your doctor you want to stay on treatment for at least 12 weeks to get the best results.
Is XERMELO right for you?
If your current treatment isn’t allowing you to live your life the way you want, adding XERMELO to your treatment plan could make a big difference.
Learn more by downloading the XERMELO brochure and then use the discussion guide to talk to your doctor about how XERMELO could help.
- Kulke MH, Hörsch D, Caplin ME, et al. Telotristat ethyl, a tryptophan hydroxylase inhibitor for the treatment of carcinoid syndrome. J Clin Oncol. 2017;35(1):14-23.
- XERMELO Prescribing Information. Deerfield, IL: TerSera Therapeutics LLC.